Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

IDH1/2 gene status defines the prognosis and molecular profiles in patients with grade III gliomas

5 Oct 2011

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Brain Metastases and Treatment
Share to Glioma Diagnosis and Treatment
Share to Neurofibromatosis and Schwannoma Cases

Source

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Identifiers

PMID: 21971842
DOI: 10.1007/s10147-011-0323-2

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

IDH1/2 gene status defines the prognosis and molecular profiles in patients with grade III gliomasPMID 21971842Read ↗

New insights into glioma classification based on isocitrate dehydrogenase 1 and 2 gene status.Semantic proximity Read ↗

The Evolving Role of Molecular Markers in the Diagnosis and Management of Diffuse GliomaSemantic proximity Read ↗

Detection of IDH1 mutation in human gliomas: comparison of immunohistochemistry and sequencingSemantic proximity Read ↗

Isocitrate Dehydrogenase IDH1 and IDH2 Mutations in Human Cancer: Prognostic Implications for Gliomas.Semantic proximity Read ↗

IDH mutations: genotype-phenotype correlation and prognostic impact.Semantic proximity Read ↗

IDH2 mutations are commonly associated with 1p/19q codeletion in diffuse adult gliomas.Semantic proximity Read ↗

IDH1/IDH2 mutations define the prognosis and molecular profiles of patients with gliomas: a meta-analysis.Semantic proximity Read ↗

IDH1/2 mutation status combined with Ki-67 labeling index defines distinct prognostic groups in glioma.Semantic proximity Read ↗

Molecular classification of diffuse cerebral WHO grade II/III gliomas using genome- and transcriptome-wide profiling improves stratification of prognostically distinct patient groups.Semantic proximity Read ↗

Journal of Neuro Oncology: Diagnostic and therapeutic implications of IDH mutations in gliomas following the 2021 World Health Organization classification of CNS tumors.Semantic proximity Read ↗

Molecular Characterization of IDH Wild-type Diffuse Astrocytomas: The Potential of cIMPACT-NOW Guidelines.Semantic proximity Read ↗

Clinical and Molecular Features of Patients with Gliomas Harboring Idh1 Non-Canonical Mutations: A Systematic Review and Meta-Analysis.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.